New guideline for treating Allan-Herndon-Dudley syndrome

Allan-Herndon-Dudley syndrome is a rare congenital disease of thyroid metabolism. It occurs in approximately 1 out of every 70,000 male newborns, and its effects are devastating. Since early 2025, a medication has been approved ...

New approach to gene correction for iron storage disease

Hereditary primary hemochromatosis is caused by a single faulty building block in a gene. This leads to iron overload, which can have serious consequences for organs and joints. In preclinical studies, researchers have already ...

page 1 from 9